Aurobindo
Novartis sells key Sandoz US portfolios to Aurobindo for $1bn
September 6, 2018Sales and Marketing Aurobindo, Novartis, Sandoz, pharma
Novartis has revealed it is to sell the dermatology and generic US oral solids portfolios of its generics arm Sandoz …
FDA finds major manufacturing issues at key Aurobindo facility
March 5, 2018Manufacturing and Production, Sales and Marketing Aurobindo, FDA, pharma
Indian pharmaceutical firm Aurobindo has been rocked by an USFDA review which identified nine major issues with its Unit 4 …
FDA approves first generic versions of Lilly’s ADHD drug
May 31, 2017Research and Development, Sales and Marketing ADHD, Apotex, Aurobindo, FDA, Glenmark, Teva
The FDA has given its approval for the commercialisation of the first-ever generic versions of Eli Lilly’s Strattera (atomoxetine) for …
EMA recommends suspension of 331 drugs over testing concerns
March 28, 2017Manufacturing and Production, Sales and Marketing Aurobindo, Micro Therapeutic Research Labs, Novartis, Sandoz
The EMA’s Committee for Medicinal Products for Human Use (CHMP) has called for the suspension of 331 drugs due to …
Actavis makes Aurobindo sale
January 21, 2014Sales and Marketing Actavis, Aurobindo, India, generics
Actavis is to sell its commercial operations in seven European countries to Aurobindo Pharma in a bid to put more …
Aurobindo forms Russian joint venture with Diod
September 13, 2011Manufacturing and Production, Sales and Marketing Aurobindo, Diod, pharma manufacturing news
Indian drugmaker Aurobindo has formed a joint venture with Russia’s OJSC Diod in order to tap into the local market …
Manufacturing news in brief
December 1, 2009Manufacturing and Production Aurobindo, Servier
Our periodic round-up of developments in the pharmaceutical manufacturing sector reveals a crop of facility news, with capital investments at …
